Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Samsung Biologics Issues Its First Annual Sustainability Report 2021-06-25 09:01
Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE 2021-06-24 20:43
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial 2021-06-23 21:21
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections 2021-06-23 19:28
Asieris Announces First Patient Treated in Europe in APRICITY, the Multinational Phase III Clinical Trial of APL-1702, Cevira® 2021-06-22 13:15
I-Mab Appoints International Gastrointestinal Oncology Expert Dr. Andrew Zhu to its Scientific Advisory Board 2021-06-21 20:00
VNTC confirms Dong-A ST its sole distributor of scoliosis brace Spinamic in South Korea 2021-06-16 00:00
Frontera Therapeutics Starts GMP Manufacturing Facility Construction 2021-06-15 23:32
Bridge Biotherapeutics Announces the Initiation of Patient Dosing in the Proof of Clinical Principle Study for BBT-401, an Investigational Drug for Ulcerative Colitis 2021-06-14 06:00
ImmVira completed the first dosing for Phase II of MVR-T3011 (intratumoral injection) in the U.S. and China 2021-06-12 11:16
Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ selective inhibitor, in relapsed or refractory follicular lymphoma at the European Hematology Association 2021 Congress 2021-06-11 13:05
Happiness Biotech Entered Into Electric Vehicle Distribution Agreement With Geely's Subsidiary 2021-06-10 21:00
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China 2021-06-10 14:00
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer 2021-06-09 21:00
China Pharma to Launch Highly Purified NMN+PQQ Product 2021-06-09 20:00
Study of Paxalisib in Primary CNS Lymphoma at Dana-Farber Cancer Institute Enrols First Patient 2021-06-07 20:00
China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection 2021-06-03 22:15
Shanghai Asclepius Meditec and International Department of Central Committee of CPC Collaborate to Provide Emergency Support to Fight COVID-19 in Nepal 2021-06-02 20:00
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate 2021-06-02 19:00
Daewoong Pharmaceutical Publishes Results of First Clinical Study of SGLT-2 Inhibitor 'Enavogliflozin' for Canine Diabetes 2021-06-01 21:00
1 109 110 111 112 113 171